HSPG2 and familial pancreatic carcinoma: SILAC-based secretome analysis from pancreatic cancer revealed an alteration in proteins such as cathepsin D, perlecan (HSPG2), fibronectin receptor (integrin β1), CD9 antigen, and profilin 1 proteins [90].